v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 28,596 $ 25,312
Short-term investments 3,424 3,801
Accounts receivable, net 24,142 22,365
Other current receivables, net 28,582 26,089
Prepaid expenses and other current assets 8,955 8,212
Total current assets 93,699 85,779
Long-term investments 52,466 52,354
Property, equipment and capitalized software, net 10,923 10,553
Goodwill 107,677 106,734
Other intangible assets, net 22,510 23,268
Other assets 21,298 19,590
Total assets 308,573 298,278
Current liabilities:    
Medical costs payable 38,427 34,224
Accounts payable and accrued liabilities 34,330 34,337
Short-term borrowings and current maturities of long-term debt 5,698 4,545
Unearned revenues 3,032 3,317
Other current liabilities 29,294 27,346
Total current liabilities 110,781 103,769
Long-term debt, less current maturities 73,495 72,359
Deferred income taxes 3,804 3,620
Other liabilities 15,709 15,939
Total liabilities 203,789 195,687
Commitments and contingencies (Note 7)
Redeemable noncontrolling interests 4,315 4,323
Equity:    
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0
Common stock, $0.01 par value - 3,000 shares authorized; 905 and 915 issued and outstanding 9 9
Retained earnings 97,250 96,036
Accumulated other comprehensive loss (2,535) (3,387)
Nonredeemable noncontrolling interests 5,745 5,610
Total equity 100,469 98,268
Total liabilities, redeemable noncontrolling interests and equity $ 308,573 $ 298,278
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10 10
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 3,000 3,000
Common stock, shares issued 905 915
Common stock, shares outstanding 905 915